| |
 |
Details: |
 |
|
|
Manufacturers of active pharma ingredients and bulk drug intermediates. Company profile, product and contact details.
|
| URL: |
http://www.astralpharmaceutical.com
|
| Title: |
Pharmaceutical Manufacturing Company India. |
| Image: |
 |
| Description: |
Business, Biotechnology and Pharmaceuticals, Pharmaceuticals, Raw Materials - Astral Pharmaceuticals. Manufacturers of active pharma ingredients and bulk drug intermediates. |
| Similar: |
|
|
|
Related Sites |
|
Sourcetech Química (Popularity:  ): Brazilian company dedicated to the development and the production of raw materials and drugs from natural origin.
Spectrum Laboratory Products, Inc. (Popularity: ): A customer-focused manufacturer and distributor of high quality chemicals, safety products and lab equipment for the laboratory and manufacturing facility.
Richman Chemical, Inc. (Popularity: ): Custom manufacturing and fine chemical sourcing for the chemical and pharmaceutical industries.
Materials Processing Technology, Inc. (Popularity: ): Production of superior value-added bulk products for the pharmaceutical, food and specialty chemical industries.
Intertrade Exim (Popularity: ): Competitive sourcing of pharmaceutical bulk drugs and intermediates, chemicals and agrochemicals from India and China.
Polyphenols AS (Popularity: ): A company based on the production of anthocyanins and other polyphenols with high purity.
Wenzhou Opal Chemical Industry Co., Ltd. (Popularity: ): Manufacturer of cimetidine intermediates series, 4-methyl imidazole, pyruvaldehyde (methyl glyoxal), and pyruvate.
SPECS and BioSPECS B.V. (Popularity: ): Provider of synthetic organic compound library's for HTS in vials or plates.
Courtin & Warner, Ltd. (Popularity: ): Suppliers of pharmaceutical active materials, essential oils, crude drugs. Also offer pre-processing and re-packaging services.
Clarion Drugs Ltd (Popularity: ): Manufacturers of pharmaceutical chemicals, including bulk actives and intermediates. Located at Tumsar.
North China Pharmaceutical Huasheng Co., Ltd. (Popularity: ): Products include streptomycin sulphate and dihydrostreptomycin sulphate.
Virchow Laboratories (Popularity: ): Manufacturers of pharmaceutical ingredients used in bulk drugs and medicines. Prime in the production of sulfamethoxazole. Company profile, product and ...
|
|
Popular Sites |
|
Richman Chemical, Inc. (Popularity: ): Custom manufacturing and fine chemical sourcing for the chemical and pharmaceutical industries.
Tianjin Tiancheng Pharmaceutical Co., Ltd. (Popularity: ): Produces pharmaceutical raw materials, pharmaceutical intermediates and chemical products.
Orgamol S.A. (Popularity: ): Swiss manufacturer of fine chemicals, active pharmaceutical ingredients, pharmaceutical intermediates and generics.
SPECS and BioSPECS B.V. (Popularity: ): Provider of synthetic organic compound library's for HTS in vials or plates.
Spectrum Laboratory Products, Inc. (Popularity: ): A customer-focused manufacturer and distributor of high quality chemicals, safety products and lab equipment for the laboratory and manufacturing facility.
|
|
Related Press |
|
Great Lakes Pharmaceuticals, Inc., Announces $2.4 Million Equity Financing (Popularity: ): Great Lakes Pharmaceuticals, Inc. announced today the completion of Series A $2.4 million equity financing led by Ohio investment funds ...
Symbollon Pharmaceuticals, Inc. Evaluates the Clinical Effects of IoGen(TM) on Fibrocystic Breast Disease (Popularity: ): Iodine has been used as an antimicrobial for the last century. Much has been written about molecular iodine yet many ...
Watson' Launches Generic Kadian(R) (Popularity: ): PARSIPPANY, N.J., Nov. 10, 2011 -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that it has received approval from the ...
Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis (Popularity: ): Cerimon Pharmaceuticals, Inc., announced today it has initiated a Phase II proof-of-concept study of Simulect(R) (basiliximab) for the treatment of ...
DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease (Popularity: ): Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing anti-inflammatory drugs, announced today that after completing its review of safety ...
|
|
Related Articles |
|
|
|
|
